Anhui Palo Alto Pharmaceuticals, Inc.

This early-stage study tested the safety and how the body processes a new nasal spray called PA9159, intended for treating allergic rhinitis (hay fever). It involved 36 healthy Chinese adults who received either the spray or a placebo for one day or seven days. The main goal was …

This early-stage study tested a new inhaled steroid called PA9159, intended for controlling asthma. It involved 40 healthy adults in China to check for side effects and see how the body processes the drug. Participants received either a single dose or took the inhaler twice daily…